Dr Pavan Kumar Mallikarjun

• PhD
• Member of Royal College of Psychiatrists (MRCPsych)
• Diploma in Psychological Medicine (DPM)
• MBBS

Pavan has completed a Medical Degree from India. He completed his Psychiatry training in India and subsequently in Birmingham, obtaining the Membership of the Royal College of Psychiatrists. His Higher Specialist Training was completed in Nottingham, where he worked as a Clinical Lecturer at the University of Nottingham. Pavan completed his PhD on Co-ordination of Brain Activity in Schizophrenia using multimodal imaging techniques including EEG and fMRI. He has been a Consultant Psychiatrist since 2009, and has been a Consultant Psychiatrist for the Early Intervention in Psychosis Service since 2010.  Pavan is currently working for Forward Thinking Birmingham. He was the Clinical Lead for the Birmingham & Solihull Early Intervention Service. 

• BMedSc Intercalated Degree

Pavan is interested in supervising graduate students in topics related to the investigation of psychopathology, pathophysiology, and treatment of mental disorders including psychosis and mood disorders.

If you are interested in studying any of these subject areas please contact Pavan on the contact details above, or for any general doctoral research enquiries, please email: dr@contacts.bham.ac.uk or call +44 (0)121 414 5005.

For a full list of available Doctoral Research opportunities, please visit our Doctoral Research programme listings.

Pavan’s research interests include delineation of the mental and neuronal processes that underlie the symptoms of mental disorder including Psychosis using multimodal imaging techniques including EEG and fMRI.

Current projects include:

1. Aberrant Cognitive Control in First Episode Psychosis: A concurrent EEG/fMRI investigation into the aberrant neural synchrony, cognitive control and functional dysconnectivity in Psychosis to test the hypothesis that in patients with psychosis there is aberrant interactions between the distributed brain networks which could explain the nature of symptoms that are seen in clinical practice.

2. BioPoP: Biological correlates of dimensional symptoms of psychosis. This study aims to discover whether neuroimaging and cellular biomarkers can be identified for specific symptom dimensions in first episode psychosis. This has important implications for the accurate early identification of patients with poor prognosis and the development of novel, targeted, treatments.

Previous research includes Investigation of coordination of brain activity in Psychosis using concurrent EEG/fMRI; and randomised controlled trail of a novel antipsychotic versus Chlorpromazine in treatment resistant Psychosis (Phase 3 Clinical Trial).